• About
  • Services
  • Blog
  • Podcasts
  • Contact
  • About
  • Services
  • Blog
  • Podcasts
  • Contact

  • Health Policy Check Up News

    Our blog provides timely insight on the latest industry trends. We discuss manufacturing, acute and post-acute care issues.

    • Stay current with our latest insights.

    April 8, 2019

    FDA Seeking Comments on New Guidance Regarding Rare Diseases

    March 29, 2019

    What You Need to Know about Biosimilars with Brian Lehman, Director, Medical Account Management and Strategic Alliances for Sandoz Inc.

    March 28, 2019

    Biosimilar Naming: Where We’ve Been and Where We Are

    March 27, 2019

    Will PBM Transparency Help Biosimilar Utilization?

    March 22, 2019

    2019 Specialty Drug Pipeline & Policy Outlook: A Glimpse into Potential Blockbuster Drugs and the Policies that Govern Them Webinar Recording

    March 14, 2019

    Don’t Ignore the Steady Drumbeat of Drug Importation

    March 12, 2019

    ONC and CMS Introduce Proposed Rules on Target Data Blocking

    February 8, 2019

    Sweeping Proposed Rule on Rebate Safe Harbor has Potential to Impact all Drug Supply Chain Stakeholders

    February 6, 2019

    New FDA Proposed Rule Looking to Define the Term “Biological Product” Seeks Comments

    February 4, 2019

    Comments Wanted: New ICER Report to Assess if Clinical Evidence Exists for Significant Increase in Prescription Drug Prices

    • First
    • Previous
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • Next
    • Last

    © 2022 Frier Levitt Government Affairs. All Rights Reserved.